CDSCO examines export feasibility of hand sanitisers
Asks States /UTs to assess production, market availability of hand sanitisers
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
NPPA
CDSCO to assess issues in the procurement and prices of APIs
This step is being taken by the authorities after media reports and representation by different pharma associations raise concerns…
NPPA allows six paracetamol APIS manufacturers to export 2000 MT
Permissions have been granted to Farmson Pharmaceuticals, Meghmani LLP, Sri Krishna Pharmaceutical, Granules India, Bharat…
State Drug Controllers asked to help pharmaceutical firms in augmenting production of medicines
Secretary, DOP appreciated the efforts of all SDC’s and requested them to provide all support to manufacturing units with the help…
DCGI instructs SDCs to monitor supply and availability of paracetamol tablets, APIs
Manufacturers of paracetamol tablets need to supply the minimum quantity but not less than their average supply of the past three…
DGFT lifts export ban on paracetamol formulations
Export restrictions on paracetamol APIs to continue, industry hopeful that the government will lift restrictions on APIs as well
NPPA revises ceiling price of scheduled formulations
Increase in ceiling price is based on Wholesale Price Index (WPI) which is 1.88468 percent
NPPA to ensure unobstructed movement of pharma related goods across India
Pharma industry along with retail chemists, wholesalers, pharma C&F agents of drugs and medicines and other members associated…
No shortage of APIs and formulations in the country, says Government
NPPA has informed that they have not received any reference regarding shortage of active pharmaceutical ingredients. IDMA has…
Alliance of Doctors for Ethical Healthcare meets NPPA head to ensure uniformity and transparency in…
The committee had previously submitted its report on 9th December 2015 demanding capping of drug prices